Bottom line
How much do RXL and IXJ overlap?
73% of their top holdings overlap by weight. 18 securities appear in both funds' top 25, making up 60.3% of RXL's assets and 54.4% of IXJ's. They are largely the same portfolio — owning both adds little diversification.
Updated Nov 22, 2026
Overlap at a glance
Holdings RXL and IXJ have in common
| Holding | % of RXL | % of IXJ | Overlap |
|---|---|---|---|
| Eli Lilly & Co. | 12.67% | 10.93% | 10.93% |
| Johnson & Johnson | 7.86% | 7.04% | 7.04% |
| AbbVie, Inc. | 5.57% | 5.12% | 5.12% |
| UnitedHealth Group, Inc. | 4.98% | 4.40% | 4.40% |
| Merck & Co., Inc. | 4.26% | 4.12% | 4.12% |
| Thermo Fisher Scientific, Inc. | 2.68% | 2.42% | 2.42% |
| Amgen, Inc. | 2.62% | 2.54% | 2.54% |
| Gilead Sciences, Inc. | 2.41% | 2.04% | 2.04% |
| Intuitive Surgical, Inc. | 2.18% | 1.83% | 1.83% |
| Pfizer, Inc. | 2.15% | 1.78% | 1.78% |
| Abbott Laboratories | 2.15% | 2.05% | 2.05% |
| Bristol-Myers Squibb Co. | 1.68% | 1.53% | 1.53% |
| CVS Health Corp. | 1.67% | 1.71% | 1.67% |
| Danaher Corp. | 1.66% | 1.56% | 1.56% |
| Vertex Pharmaceuticals, Inc. | 1.64% | 1.64% | 1.64% |
| Stryker Corp. | 1.52% | 1.41% | 1.41% |
| McKesson Corp. | 1.32% | 1.18% | 1.18% |
| Elevance Health, Inc. | 1.26% | 1.09% | 1.09% |
Source: SEC Form N-PORT (periods May 31, 2026 / Jun 30, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in RXL
- ProShares GENIUS Money Market ETF — 11.81%
- Repurchase Agreement — 2.91%
- Repurchase Agreement — 1.83%
- Repurchase Agreement — 1.37%
- Medtronic plc — 1.37%
- Cigna Group (The) — 1.06%
- Boston Scientific Corp. — 1.04%
Only in IXJ
- Astrazeneca Plc — 3.76%
- Roche Holding AG — 3.75%
- Novartis AG — 3.71%
- Novo Nordisk A/s — 1.99%
- Gsk Plc — 1.38%
- Medtronic Public Limited Company — 1.30%
- Sanofi Sa — 1.18%
Asset mix
| Asset type | RXL | IXJ |
|---|---|---|
| Stocks | 78.0% | 99.6% |
| Other | 11.8% | — |
| Repurchase agreements | 7.1% | — |
| Cash & short-term funds | — | 1.3% |
Source: SEC Form N-PORT (periods May 31, 2026 / Jun 30, 2026)
Country mix
| Country | RXL | IXJ |
|---|---|---|
| US | 85.6% | 70.6% |
| CH | — | 10.4% |
| GB | — | 5.8% |
| JP | — | 3.7% |
| DK | — | 2.3% |
| FR | — | 2.0% |
| IE | 1.7% | 1.6% |
| DE | — | 1.6% |
Source: SEC Form N-PORT (periods May 31, 2026 / Jun 30, 2026)
Check another pair
FAQ
How much do RXL and IXJ overlap?
What stocks do RXL and IXJ have in common?
Should I own both RXL and IXJ?
Which holds more stocks, RXL or IXJ?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.